Price · last 3 months · daily close
WY price
Loading the price chart...
Daily closing prices via yfinance. Quotes are delayed. Past prices are not a guarantee of future results.
ValeriusBeta - Not investment advice
Research · S&P 500 · Real Estate
The numbers, the scorecard and what analysts say, with the source for each. Information, not advice.
Price · last 3 months · daily close
Loading the price chart...
Daily closing prices via yfinance. Quotes are delayed. Past prices are not a guarantee of future results.
Value Scorecard · run 2026-10-19
The REIT version isn't used for this company: its 10-K filings have no Nareit FFO line. Its checks are the standard ones, which don't fully fit how a REIT works.
Earnings & returns
Diluted EPS: $2.53 (2022), $1.15 (2023), $0.54 (2024), $0.45 (2025). The latest figure is half the 2022 figure or less; the framework scores that as 1.
ROE (net income / common equity): 17.5% (2022), 8.2% (2023), 4.1% (2024), 3.4% (2025). Median 6.1%, lowest 3.4%; the framework scores a median 5-10% as 2.
ROIC of 4.8%: operating income of $731.00M divided by $15.34B of capital (total assets $16.61B minus current liabilities $1.28B), fiscal year to Dec 31, 2025, as filed in the 10-K (SEC EDGAR). The framework scores below 5% as 1.
Net margin of 6.9%; the framework scores 5-10% as 3; gross margin 14.5%, operating margin 8.0%.
Balance sheet & cash
Debt-to-equity of 0.58; the framework scores 0.3-0.8 as 4 (total debt $5.45B, total cash $527.00M).
Free cash flow (operating cash flow minus capital expenditure): $2.36B (2022), $753.00M (2023), $341.00M (2024), -$381.00M (2025). The latest figure is at or below zero; the framework scores that as 1.
Retained earnings, as filed in the 10-Ks (SEC EDGAR): $2.39B (2022), $2.01B (2023), $1.72B (2024), $1.43B (2025). It ended at or below 2022; the framework scores that as 2.
Valuation models
IV = EPS x (8.5 + 2g) x (4.4 / Y) = $0.65 x (8.5 + 2 x 0.0) x (4.4 / 4.5) = $5.40 (EPS CAGR -37.4% floored at 0%; the formula returns a negative value below -4.25% growth). Current price $19.20; price is 255.4% above the model value.
FCF/share = $0.019, stage 1 growth = 0.0% (revenue CAGR -5.1% floored at 0%; the company is valued as if it does not grow rather than extrapolating the decline) for 5 years, terminal growth = 3%, discount rate = 10%. Stage 1 PV = $0.07, PV of terminal value = $0.17, DCF value = $0.24. Current price $19.20; price is 7756.6% above the model value.
Graham value $5.40 (price is 255.4% above the model value); DCF value $0.24 (price is 7756.6% above the model value).
P/B of 1.46; the framework scores 1.0-1.5 as 4.
Business quality
A moat (a brand, a network, switching costs, patents, scale, a licence) is not a number in the filings, so Valerius doesn’t score it. Below are the figures and the words moat analysis starts from, from the company’s own 10-K filings. The conclusion is yours.
Return on capital, each year
Above 15% in 2 of 10 years (2016-2025); lowest 4.2%, highest 21.8%.
Gross margin, each year
Between 14.8% and 40.2% over 10 years (a range of 25.4 points).
Competition, in the company’s own words · 10-K filed Feb 13, 2026
The latest 10-K has no section headed “Competition” that could be quoted. Open the filing to read how the company describes its markets.
Return on capital = operating income / (total assets − current liabilities), the ROIC row’s definition; 15% is the framework’s return threshold. Gross margin = gross profit / revenue. Both from each year’s 10-K via SEC EDGAR. Moat analysis commonly looks at whether returns and margins held up over many years. These figures don’t say whether the company has an advantage, what it is, or whether it will last.
Capital allocation, 2022-2025: dividends or buybacks paid in every year (pass); $5.11B paid out against $3.08B of free cash flow (fail: paid out more than free cash flow); total debt $5.08B to $5.60B, up 10.3%, 5.4x EBITDA (fail: up more than 10% and above 2x EBITDA); shares outstanding 0.73B to 0.72B, down 1.7% (pass). 2 of 4 tests passed; the framework scores that as 3.
Filings
Three kinds of event the company reported to the SEC in the last 5 years, from its filings on SEC EDGAR.
Loading...
These are events the company reported to the SEC. An auditor change or a late filing can have many causes; each date links to the filing, where the company explains it. Valerius does not score these.
Graham Formula:
IV = EPS x (8.5 + 2g) x (4.4 / Y)
EPS = $0.65, g = 0.0%, Y = 4.5
g floored at 0.0% (3-year EPS CAGR was -37.4%; below -4.25% the formula returns a negative value)
IV = $5.40
Current price $19.20 vs Graham value $5.40 — price is 255.4% above the model value.
DCF:
FCF/share = $0.019
Stage 1 growth = 0.0% for 5 years | terminal growth = 3.0% | discount rate = 10.0%
Stage 1 g floored at 0.0% (3-year revenue CAGR was -5.1%; the company is valued as if it does not grow rather than extrapolating the decline)
Y1: $0.019 → PV $0.017
Y2: $0.019 → PV $0.016
Y3: $0.019 → PV $0.014
Y4: $0.019 → PV $0.013
Y5: $0.019 → PV $0.012
Stage 1 PV sum = $0.07
Terminal value at end of Y5 = $0.28
PV of terminal value = $0.17
DCF value = $0.24
Current price $19.20 vs DCF value $0.24 — price is 7756.6% above the model value.Data from yfinance summary figures and financial statements, and from the company’s 10-K filings via SEC EDGAR; computed at a price of $19.20. Every score is calculated from the figures by the framework’s fixed rules, and the explanation beside it is generated from the same figures: Graham value, DCF value, margin of safety, ROIC, profit margins, debt-to-equity, price-to-book, EPS trend, ROE trend, free cash flow, retained earnings and capital allocation. No AI is involved in this scorecard. The moat is shown as evidence, without a score. Read each score with the figures beside it. Intrinsic value calculations are model outputs based on stated assumptions, not predictions.
Recent headlines · third-party publishers · not investment advice
The 8 newest headlines whose title names the company, shown automatically and never chosen by Valerius. From third-party publishers via Yahoo Finance, linked to the source. Valerius doesn't write or endorse them. Not investment advice.